New York, NY, United States of America

Emanuel Revici

This inventor holds 23 USPTO granted patents, plus 5 CIPO patents, primarily in Pharmaceutical Compositions. Top assignees: The Vinoxen Company, F.c.n.s.r.l., Alphatime Ltd. Active years: 1981-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emanuel Revici. Retrieved from https://idiyas.com/inventor/emanuel-revici

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 1.0

ph-index = 5

Forward Citations = 112(Granted Patents)


Company Filing History:


Years Active: 1981-1992

Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Compositions
Neoplastic Diseases
Pain Relief
Immune Deficiency
Bismuth Compounds
Tung Oil
Nucleoproteins
Sodium Chloride
Copper Deficiency
Potassium Deficiency
Virucidal Compositions
Selenium Compounds
23 patents (USPTO):Explore Patents

Title: Innovations of Emanuel Revici in Medical Treatments

Introduction

Emanuel Revici was a notable inventor and medical researcher based in New York, NY. With a remarkable portfolio of 23 patents, his work primarily focused on innovative treatments for serious health conditions. His unique approach involved utilizing chemical compounds to alleviate symptoms of diseases rather than solely targeting the diseases themselves.

Latest Patents

Among Revici's significant contributions, his latest patents showcase his innovative methods for addressing complex health issues. One notable patent is a method for the treatment of acquired immune deficiency syndrome (AIDS). This composition is designed to provide an alleviating effective amount of an aliphatic carboxylic acid with an odd number of carbon atoms, specifically containing between 5 and 10 carbon atoms. This composition can be administered in a pharmaceutically acceptable oily carrier, either orally or by intramuscular injection.

Another noteworthy innovation by Revici is a method for treating the symptoms of neoplastic diseases without directly addressing the disease itself. This method includes administering an effective amount of a combination of two or more ketones, aldehydes, alcohols, or amines in a vegetable oil solution to alleviate symptoms experienced by patients suffering from neoplastic diseases.

Career Highlights

Revici's professional journey included invaluable experiences at various companies. He was associated with The Vinoxen Company, where he contributed his expertise in medical applications. His extensive knowledge and unique perspectives led to groundbreaking developments in treating critical health issues.

Collaborations

Throughout his career, Revici collaborated with several notable figures in the research community. Among them were Bob E. Sherwood and Herman P. Benecke, who worked alongside him in pursuit of medical advancements. Their collective efforts helped propel innovative solutions in healthcare that continue to influence treatments today.

Conclusion

Emanuel Revici's inventive spirit and dedication to improving health through innovative treatments have left an enduring impact on the medical field. His patents reflect a commitment to finding effective solutions for debilitating conditions, showcasing the vital role inventors play in advancing healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…